Effects of teneligliptin on serum lipid profile and insulin resistance in patients with type 2 diabetes

Effects of teneligliptin on serum lipid profile and insulin resistance in patients with type 2 diabetes - Effects of teneligliptin on serum lipid profile and insulin resistance

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000014982

Enrollment

Registered

2014-08-28

Start date

2013-02-15

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Teneligliptin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: Having severe nephropathy.

Design outcomes

Secondary

Measure	Time frame
Hemoglobin A1c, Fasting blood glucose, Serum adiponectin	—

Primary

Measure	Time frame
Serum total cholesterol, HDL-cholesterol, LDL-cholesterol, triglyceride, HOMA-R	—

Countries

Japan

Contacts

Public ContactMasataka Kusunoki

Aichi Medical University Medical Clinic

info@tonyo.jp052-931-2261

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026